SUBSCRIBE
SUBSCRIBE
News   Business

Arrowhead Research Corporation Reports Fiscal 2012 First Quarter Financial Results

February 10, 2012 | 
1 min read
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology and obesity, today announced financial results for its fiscal 2012 first quarter ended December 31, 2011.
Earnings
Arrowhead Pharmaceuticals, Inc.
MORE ON THIS TOPIC
Covid-19 vaccine race concept. Syringes flying like a missile, rocket, or jet plane. Blue background
Mergers & Acquisitions
Lilly lands vaccine trifecta with 3 new biotech buys valued at up to $3.8B
May 26, 2026
 · 
5 min read
 · 
Annalee Armstrong
A businessman stands on a high mountain with his hands raised in pride of a successful business. Business or success concept vector illustration.
Business
Lilly is pharma’s top dog, placing first in innovation and invention: IDEA
May 26, 2026
 · 
2 min read
 · 
Tristan Manalac
Investment mistakes, taxes, expenses, and unknown costs drain money, concept of Businessman carries a money bag with a big hole, banknotes falling out
Funding
Recordati fields $12.4B go-private offer
May 22, 2026
 · 
2 min read
 · 
Tristan Manalac
High Quality background with Two Flags of South Korea and USA
Manufacturing
Gilead inks $140M API supply deal, tightening ties to Korean manufacturer
May 22, 2026
 · 
1 min read
 · 
Nick Paul Taylor